Cothera Bioscience, Inc
1 clinical trials · Sponsor
◉ Watch Cothera Bioscience, Inc
| Record | Firm | Date |
|---|---|---|
| Sepantronium Bromide for the Treatment of High-grade B-cell Lymphoma (NCT05263583) | Cothera Bioscience, Inc | 2022-12-09 |
Track Cothera Bioscience, Inc automatically
Every clearance here is in the API, with alerts when new ones post.